1. Accueil
  2. Node

RETA 160 MG BT 30

* HYPERTENSION :

Treatment of essential hypertension.

* RECENT MYOCARDIAL INFARCTION :

Treatment of clinically stable patients with symptomatic heart failure or asymptomatic left ventricular systolic dysfunction following recent myocardial infarction (between 12 hours and 10 days).

RETA 80 MG BT 30

* HYPERTENSION :

Treatment of essential hypertension.

* RECENT MYOCARDIAL INFARCTION :

Treatment of clinically stable patients with symptomatic heart failure or asymptomatic left ventricular systolic dysfunction following recent myocardial infarction (between 12 hours and 10 days).

RETA 80 MG BT 90

* HYPERTENSION :

Treatment of essential hypertension.

* RECENT MYOCARDIAL INFARCTION :

Treatment of clinically stable patients with symptomatic heart failure or asymptomatic left ventricular systolic dysfunction following recent myocardial infarction (between 12 hours and 10 days).

SERVAL 25 MG BT 30

SERVAL IS INDICATED :

  • In the treatment of depression in adults, including depression associated with symptoms of anxiety. Following a satisfactory therapeutic response, continuing treatment with Serval prevents the occurrence of relapses of depressive episodes.
  • In the treatment of obsessive-compulsive disorders in adults and children (aged 6 to 12 years) and adolescents (13-17 years).

SERVAL 50 MG BT 30

SERVAL IS INDICATED :

  • In the treatment of depression in adults, including depression associated with symptoms of anxiety. Following a satisfactory therapeutic response, continuing treatment with Serval prevents the occurrence of relapses of depressive episodes.
  • In the treatment of obsessive-compulsive disorders in adults and children (aged 6 to 12 years) and adolescents (13-17 years).

SERVAL 100 MG BT 30

SERVAL IS INDICATED :

  • In the treatment of depression in adults, including depression associated with symptoms of anxiety. Following a satisfactory therapeutic response, continuing treatment with Serval prevents the occurrence of relapses of depressive episodes.
  • In the treatment of obsessive-compulsive disorders in adults and children (aged 6 to 12 years) and adolescents (13-17 years).
Subscribe to